Close

Drug Research

Introducing ReciPredict: Revolutionising Drug Product Development and Manufacturing

Recipharm announced the launch of ReciPredict, a cutting-edge platform for Quality by Design (QbD), designed to transform the landscape of drug product development, tech...

Radiopharmaceuticals : Rapid Growth And Rising Investments

The radiopharmaceutical industry is growing very quickly. In the past few years, there have been more mergers and acquisitions (M&A) and partnerships. Investors can...

GSKs Lung Cancer ADC Earns FDA Breakthrough Designation

The FDA has granted breakthrough status to an antibody-drug conjugate (ADC) that GSK licensed from China's Hansoh Pharma in a $1.7 billion agreement last...

Bayer And NextRNA Partner On New Small Molecule Cancer Drugs

Bayer and NextRNA Therapeutics, a biotechnology company, announced that they would be working together to create a new type of small molecule cancer drug....

Strategies To Improve Cell Line Development For Biologics

The capacity of a cell line to create a biologic that is both safe and stable in large numbers may be considerably improved by...

Nuclear Medicine In North America: Market Growth & Trends

The North American nuclear medicine market was estimated to be worth USD 2.05 billion in 2023 and is expected to develop rapidly over the...

Bayer & NextRNA Partner In $547Million Cancer Therapy Deal

This summer, Bayer officials made sure Fierce understood that the company's desire for deals hasn't been stifled by a group-wide reorganization. Its most recent...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read